You are here

  • Home
  • Online First
  • PAZEC: a Dutch Gynaecological Oncology Group open-label, multicenter, phase II study of pazopanib in metastatic and locally advanced hormone-resistant endometrial cancer

Article metrics

Article menu

other Versions

Download PDFPDF
Original research
PAZEC: a Dutch Gynaecological Oncology Group open-label, multicenter, phase II study of pazopanib in metastatic and locally advanced hormone-resistant endometrial cancer

 

Online download statistics by month:

Online download statistics by month: January 2024 to October 2024

AbstractFullPdf
Jan 202410763221
Feb 20246382618
Mar 2024312159
Apr 202414475
May 202414866
Jun 202430082
Jul 2024737101
Aug 20247941
Sep 202412652
Oct 20241500
Total357511365